Literature DB >> 17187246

Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome.

T Benfield1, J S Jensen, B G Nordestgaard.   

Abstract

AIMS/HYPOTHESIS: Diabetes mellitus is believed to increase susceptibility to infectious diseases. The effects of hyperglycaemia per se on infectious disease risk are unknown and the influence of diabetes on infectious disease outcome is controversial.
MATERIALS AND METHODS: We studied 10,063 individuals from the Danish general population, who were participants in The Copenhagen City Heart Study, over a follow-up period of 7 years. Risk of hospitalisation caused by any infectious disease, and subsequent risk of disease progression to death were estimated by Cox proportional hazards regression analysis.
RESULTS: At baseline, 353 individuals reported having diabetes. During 71,509 person-years of follow-up, a total of 1,194 individuals were hospitalised because of an infection. The risk of pneumonia (adjusted hazard ratio [aHR] 1.75, 95% CI 1.23-2.48), urinary tract infection (aHR 3.03, 95% CI 2.04-4.49) and skin infection (aHR 2.43, 95% CI 1.49-3.95) was increased in subjects with diabetes compared with subjects without. Each 1 mmol/l increase in plasma glucose at baseline was associated with a 6-10% increased relative risk of pneumonia, urinary tract infection and skin infection after adjustment for other possible confounders. Among patients hospitalised for urinary tract infection, diabetic patients were at an increased risk of death at 28 days after admission compared with non-diabetic subjects (HR 3.90, 95% CI 1.20-12.66). CONCLUSIONS/
INTERPRETATION: In the Danish general population, diabetes and hyperglycaemia are strong and independent risk factors for hospitalisation as a result of pneumonia, urinary tract infection and skin infection. Further, diabetes has a negative impact on the prognosis of urinary tract infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187246     DOI: 10.1007/s00125-006-0570-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

Review 1.  Infections in patients with diabetes mellitus.

Authors:  N Joshi; G M Caputo; M R Weitekamp; A W Karchmer
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

2.  Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters.

Authors:  D Popov; M Simionescu
Journal:  Eur Respir J       Date:  1997-08       Impact factor: 16.671

3.  Asymptomatic bacteriuria in women with diabetes: influence of metabolic control.

Authors:  Mario Bonadio; Elisabetta Boldrini; Giovanna Forotti; Elena Matteucci; Armando Vigna; Stefano Mori; Ottavio Giampietro
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079

4.  Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.

Authors:  L M A J Muller; K J Gorter; E Hak; W L Goudzwaard; F G Schellevis; A I M Hoepelman; G E H M Rutten
Journal:  Clin Infect Dis       Date:  2005-06-16       Impact factor: 9.079

Review 5.  Diabetic autonomic neuropathy.

Authors:  D J Hosking; T Bennett; J R Hampton
Journal:  Diabetes       Date:  1978-10       Impact factor: 9.461

6.  Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients.

Authors:  B J Philips; J Redman; A Brennan; D Wood; R Holliman; D Baines; E H Baker
Journal:  Thorax       Date:  2005-09       Impact factor: 9.139

7.  Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.

Authors:  R Valdez; K M Narayan; L S Geiss; M M Engelgau
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

8.  Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women.

Authors:  Edward J Boyko; Stephan D Fihn; Delia Scholes; Linn Abraham; Barbara Monsey
Journal:  Am J Epidemiol       Date:  2005-03-15       Impact factor: 4.897

Review 9.  Manifestations of cutaneous diabetic microangiopathy.

Authors:  Binh T Ngo; Kristie D Hayes; Dominick J DiMiao; Shashi K Srinivasan; Christopher J Huerter; Marc S Rendell
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

10.  Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes.

Authors:  W Marhoffer; M Stein; E Maeser; K Federlin
Journal:  Diabetes Care       Date:  1992-02       Impact factor: 19.112

View more
  110 in total

1.  Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice.

Authors:  Hideaki Yamasawa; Masayuki Nakayama; Masashi Bando; Yukihiko Sugiyama
Journal:  Inflamm Res       Date:  2012-01-07       Impact factor: 4.575

2.  Risk of type 2 diabetes mellitus in patients with acute critical illness: a population-based cohort study.

Authors:  Chin-Wang Hsu; Chin-Sheng Lin; Sy-Jou Chen; Shih-Hua Lin; Cheng-Li Lin; Chia-Hung Kao
Journal:  Intensive Care Med       Date:  2015-09-14       Impact factor: 17.440

3.  Influence of diabetes on endothelial cell response during sepsis.

Authors:  P Schuetz; K Yano; M Sorasaki; L Ngo; M St Hilaire; J M Lucas; W Aird; N I Shapiro
Journal:  Diabetologia       Date:  2011-02-01       Impact factor: 10.122

4.  Urinary tract infection in diabetes: epidemiologic considerations.

Authors:  Victoire de Lastours; Betsy Foxman
Journal:  Curr Infect Dis Rep       Date:  2014-01       Impact factor: 3.725

5.  Accuracy of Continuous Glucose Monitoring in Patients After Total Pancreatectomy with Islet Autotransplantation.

Authors:  Gregory P Forlenza; Brandon M Nathan; Antoinette Moran; Ty B Dunn; Gregory J Beilman; Timothy L Pruett; Boris P Kovatchev; Melena D Bellin
Journal:  Diabetes Technol Ther       Date:  2016-04-22       Impact factor: 6.118

6.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10

7.  Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections.

Authors:  Andreas Oberbach; Nadine Schlichting; Matthias Blüher; Peter Kovacs; Holger Till; Jens-Uwe Stolzenburg; Jochen Neuhaus
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

8.  A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes.

Authors:  Ivan Gornik; Ana Vujaklija-Brajkovic; Ivana Pavlic Renar; Vladimir Gasparovic
Journal:  Crit Care       Date:  2010-07-08       Impact factor: 9.097

9.  Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes.

Authors:  Mariann Nymark; Pirkko J Pussinen; Anita M Tuomainen; Carol Forsblom; Per-Henrik Groop; Markku Lehto
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

10.  Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity.

Authors:  José Manuel Fernández-Real; Sergio Valdés; Melania Manco; Berta Chico; Patricia Botas; Arantza Campo; Roser Casamitjana; Elías Delgado; Javier Salvador; Gema Fruhbeck; Geltrude Mingrone; Wifredo Ricart
Journal:  Diabetes Care       Date:  2010-01-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.